For almost 20 years, DMD America has assisted our clients in complying with Vermont’s Pharmaceutical Marketer Price Disclosure law and, more recently, Colorado and Connecticut’s Drug Price Transparency laws. Our full-service program builds and updates your compliance forms from the ground up, so you don’t have to.
Please don't hesitate to reach out to us with additional government transparency laws and/or compliance needs that you may have.
Already producing these forms? We offer a no-cost analysis of any form you submit with our expert feedback. You have nothing to lose!
Colorado’s HB19-1131 Prescription Drug Cost Education Act requires a drug manufacturer, or a representative, agent, or employee of the manufacturer, who while employed by or under contract to represent a manufacturer engages in prescription drug marketing, to provide to a prescriber, in writing, the wholesale acquisition cost of a prescription drug when, in the course of conducting business, the manufacturer, representative, agent, or employee provides information concerning the drug to the prescriber.
The act also requires the drug manufacturer, or a representative, agent, or employee of the manufacturer, to disseminate the names of at least 3 generic prescription drugs from the same therapeutic class, or if 3 are not available, as many as are available for prescriptive use.
Connecticut’s Substitute House Bill No. 6669 – Public Act No. 23-171 (“An Act Protecting Patients and Prohibiting Unnecessary Health Care Costs”) requires that each pharmaceutical representative engaged in legend drug marketing in the state shall disclose, in writing, to a prescribing practitioner or pharmacist, the following information: (1) The list price of a legend drug when such pharmaceutical representative provides information concerning such legend drug to the prescribing practitioner or pharmacist based on the dose and quantity of such legend drug as described in the medication package insert; and (2) Information on the variation efficacy of the legend drug marketed to different racial and ethnic groups, if such information is available.
Vermont’s Pharmaceutical Marketer Price Disclosure law, 18 V.S.A. § 4633, requires pharmaceutical marketers to provide prescribers with comparative price information, so they can take list price into consideration when prescribing drugs within a therapeutic class.